Anti-cancer therapies and cardiovascular disease
| Code | School | Level | Credits | Semesters |
| MEDS3001 | Medical Education Centre | 3 | 10 | Autumn UK |
- Code
- MEDS3001
- School
- Medical Education Centre
- Level
- 3
- Credits
- 10
- Semesters
- Autumn UK
Summary
A number of therapeutic approaches are used in the treatment of cancer. Several of the newer cancer therapies, specifically those that inhibit angiogenesis (i.e., vascular endothelial growth factor (VEGF)), have improved rates of patient morbidity and mortality. However, often these patients are subsequently at a higher risk of developing cardiovascular disease. This module focuses on how cancer therapies have developed in recent years, and how the long-term cardiovascular effects of these treatments, in cancer survivors, should be considered.
6 lectures to address:
Target Students
Students registered on the A100 BMedSci, A10S BMedSci and A104 BSc Medical Sciences.There is a limited number of places on this module. Students are reminded that enrolments which are not agreed by the Offering School in advance may be cancelled without notice.
Classes
- Two 1-hour lectures each week for 3 weeks
Lectures - please refer to module timetable online for up to date information on contact hours. Directed reading linked to an assessment task.
Assessment
- 100% Coursework 1: Maximum 2000 words.
Assessed by end of autumn semester
Educational Aims
The module is designed so that students can attain some of the outcomes specified by the GMC in Outcomes for Graduates (2018) in the areas of Professional values and behaviours; Professional skills; and Professional knowledge. These are detailed in the Module Learning Outcomes.This module is part of a group of student selected Advanced Medical Science modules. During these modules students will be building on previous learning and acquiring knowledge, skills and attitudes required for assessment and management of patients with a core spectrum of clinical presentations and conditions. This module aims to establish an understanding of the long-term impact of cancer therapies on the cardiovascular system.This will predominantly be within the homebases and there is a requirement for students to carry out significant private study including reading advanced texts, review articles and research papers on specialist medical science topics.It will be essential to demonstrate appropriate professional attitudes and behavior.Learning Outcomes
By the end of the module, students will be able to:
• Build on previous learning and acquiring knowledge, skills and attitudes required for assessment and management of patients with a core spectrum of clinical presentations and conditions
• Gain an understanding of the long-term impact of cancer therapies on the cardiovascular system
Medical students are tomorrow’s doctors. In accordance with Good medical practice, newly qualified doctors must make the care of patients their first concern, applying their knowledge and skills in a competent, ethical and professional manner and taking responsibility for their own actions in complex and uncertain situations.
The student will be able to meet areas within the GMC outcomes as follows. The full wording is found in GMC Outcomes for Graduates (2018) and in module study guides using the paragraph numbers.
2g, 2k, 2p, 2s, 5a, 6a, 6b, 6e, 22a, 22b, 22c, 22d, 22e, 22f